122 related articles for article (PubMed ID: 38485837)
21. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
Makishima H; Saiki R; Nannya Y; Korotev S; Gurnari C; Takeda J; Momozawa Y; Best S; Krishnamurthy P; Yoshizato T; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Nagata Y; Kakiuchi N; Onizuka M; Chiba K; Tanaka H; Kon A; Ochi Y; Nakagawa MM; Okuda R; Mori T; Yoda A; Itonaga H; Miyazaki Y; Sanada M; Ishikawa T; Chiba S; Tsurumi H; Kasahara S; Müller-Tidow C; Takaori-Kondo A; Ohyashiki K; Kiguchi T; Matsuda F; Jansen JH; Polprasert C; Blombery P; Kamatani Y; Miyano S; Malcovati L; Haferlach T; Kubo M; Cazzola M; Kulasekararaj AG; Godley LA; Maciejewski JP; Ogawa S
Blood; 2023 Feb; 141(5):534-549. PubMed ID: 36322930
[TBL] [Abstract][Full Text] [Related]
22. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Duncavage EJ; Bagg A; Hasserjian RP; DiNardo CD; Godley LA; Iacobucci I; Jaiswal S; Malcovati L; Vannucchi AM; Patel KP; Arber DA; Arcila ME; Bejar R; Berliner N; Borowitz MJ; Branford S; Brown AL; Cargo CA; Döhner H; Falini B; Garcia-Manero G; Haferlach T; Hellström-Lindberg E; Kim AS; Klco JM; Komrokji R; Lee-Cheun Loh M; Loghavi S; Mullighan CG; Ogawa S; Orazi A; Papaemmanuil E; Reiter A; Ross DM; Savona M; Shimamura A; Skoda RC; Solé F; Stone RM; Tefferi A; Walter MJ; Wu D; Ebert BL; Cazzola M
Blood; 2022 Nov; 140(21):2228-2247. PubMed ID: 36130297
[TBL] [Abstract][Full Text] [Related]
23. Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.
Feurstein S; Trottier AM; Estrada-Merly N; Pozsgai M; McNeely K; Drazer MW; Ruhle B; Sadera K; Koppayi AL; Scott BL; Oran B; Nishihori T; Agrawal V; Saad A; Lindsley RC; Nakamura R; Kim S; Hu Z; Sobecks R; Spellman S; Saber W; Godley LA
Blood; 2022 Dec; 140(24):2533-2548. PubMed ID: 35969835
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Döhner H; Wei AH; Appelbaum FR; Craddock C; DiNardo CD; Dombret H; Ebert BL; Fenaux P; Godley LA; Hasserjian RP; Larson RA; Levine RL; Miyazaki Y; Niederwieser D; Ossenkoppele G; Röllig C; Sierra J; Stein EM; Tallman MS; Tien HF; Wang J; Wierzbowska A; Löwenberg B
Blood; 2022 Sep; 140(12):1345-1377. PubMed ID: 35797463
[TBL] [Abstract][Full Text] [Related]
25. Discrepancies between tumor genomic profiling and germline genetic testing.
Pauley K; Koptiuch C; Greenberg S; Kohlmann W; Jeter J; Colonna S; Werner T; Kinsey C; Gilcrease G; Weis J; Whisenant J; Florou V; Garrido-Laguna I
ESMO Open; 2022 Aug; 7(4):100526. PubMed ID: 35780590
[TBL] [Abstract][Full Text] [Related]
26. Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.
McReynolds LJ; Rafati M; Wang Y; Ballew BJ; Kim J; Williams VV; Zhou W; Hendricks RM; Dagnall C; Freedman ND; Carter B; Strollo S; Hicks B; Zhu B; Jones K; Paczesny S; Marsh SGE; Spellman SR; He M; Wang T; Lee SJ; Savage SA; Gadalla SM
Blood; 2022 Aug; 140(8):909-921. PubMed ID: 35776903
[TBL] [Abstract][Full Text] [Related]
27. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Arber DA; Orazi A; Hasserjian RP; Borowitz MJ; Calvo KR; Kvasnicka HM; Wang SA; Bagg A; Barbui T; Branford S; Bueso-Ramos CE; Cortes JE; Dal Cin P; DiNardo CD; Dombret H; Duncavage EJ; Ebert BL; Estey EH; Facchetti F; Foucar K; Gangat N; Gianelli U; Godley LA; Gökbuget N; Gotlib J; Hellström-Lindberg E; Hobbs GS; Hoffman R; Jabbour EJ; Kiladjian JJ; Larson RA; Le Beau MM; Loh ML; Löwenberg B; Macintyre E; Malcovati L; Mullighan CG; Niemeyer C; Odenike OM; Ogawa S; Orfao A; Papaemmanuil E; Passamonti F; Porkka K; Pui CH; Radich JP; Reiter A; Rozman M; Rudelius M; Savona MR; Schiffer CA; Schmitt-Graeff A; Shimamura A; Sierra J; Stock WA; Stone RM; Tallman MS; Thiele J; Tien HF; Tzankov A; Vannucchi AM; Vyas P; Wei AH; Weinberg OK; Wierzbowska A; Cazzola M; Döhner H; Tefferi A
Blood; 2022 Sep; 140(11):1200-1228. PubMed ID: 35767897
[TBL] [Abstract][Full Text] [Related]
28. Revision of RUNX1 variant curation rules.
Feurstein S; Luo X; Shah M; Walker T; Mehta N; Wu D; Godley LA
Blood Adv; 2022 Aug; 6(16):4726-4730. PubMed ID: 35764482
[No Abstract] [Full Text] [Related]
29. ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms.
Sullivan MJ; Palmer EL; Botero JP
Curr Hematol Malig Rep; 2022 Oct; 17(5):105-112. PubMed ID: 35751752
[TBL] [Abstract][Full Text] [Related]
30. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Khoury JD; Solary E; Abla O; Akkari Y; Alaggio R; Apperley JF; Bejar R; Berti E; Busque L; Chan JKC; Chen W; Chen X; Chng WJ; Choi JK; Colmenero I; Coupland SE; Cross NCP; De Jong D; Elghetany MT; Takahashi E; Emile JF; Ferry J; Fogelstrand L; Fontenay M; Germing U; Gujral S; Haferlach T; Harrison C; Hodge JC; Hu S; Jansen JH; Kanagal-Shamanna R; Kantarjian HM; Kratz CP; Li XQ; Lim MS; Loeb K; Loghavi S; Marcogliese A; Meshinchi S; Michaels P; Naresh KN; Natkunam Y; Nejati R; Ott G; Padron E; Patel KP; Patkar N; Picarsic J; Platzbecker U; Roberts I; Schuh A; Sewell W; Siebert R; Tembhare P; Tyner J; Verstovsek S; Wang W; Wood B; Xiao W; Yeung C; Hochhaus A
Leukemia; 2022 Jul; 36(7):1703-1719. PubMed ID: 35732831
[TBL] [Abstract][Full Text] [Related]
31. The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources.
DiStefano MT; Goehringer S; Babb L; Alkuraya FS; Amberger J; Amin M; Austin-Tse C; Balzotti M; Berg JS; Birney E; Bocchini C; Bruford EA; Coffey AJ; Collins H; Cunningham F; Daugherty LC; Einhorn Y; Firth HV; Fitzpatrick DR; Foulger RE; Goldstein J; Hamosh A; Hurles MR; Leigh SE; Leong IUS; Maddirevula S; Martin CL; McDonagh EM; Olry A; Puzriakova A; Radtke K; Ramos EM; Rath A; Riggs ER; Roberts AM; Rodwell C; Snow C; Stark Z; Tahiliani J; Tweedie S; Ware JS; Weller P; Williams E; Wright CF; Yates TM; Rehm HL
Genet Med; 2022 Aug; 24(8):1732-1742. PubMed ID: 35507016
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Duployez N; Largeaud L; Duchmann M; Kim R; Rieunier J; Lambert J; Bidet A; Larcher L; Lemoine J; Delhommeau F; Hirsch P; Fenwarth L; Kosmider O; Decroocq J; Bouvier A; Le Bris Y; Ochmann M; Santagostino A; Adès L; Fenaux P; Thomas X; Micol JB; Gardin C; Itzykson R; Soulier J; Clappier E; Recher C; Preudhomme C; Pigneux A; Dombret H; Delabesse E; Sébert M
Blood; 2022 Aug; 140(7):756-768. PubMed ID: 35443031
[TBL] [Abstract][Full Text] [Related]
33. Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders.
DeRoin L; Cavalcante de Andrade Silva M; Petras K; Arndt K; Phillips N; Wanjari P; Subramanian HP; Montes D; McElherne J; Theissen M; Briese R; Das S; Godley LA; Segal J; Del Gaudio D; Fitzpatrick C; Churpek JE
Hum Mutat; 2022 Jul; 43(7):950-962. PubMed ID: 35419889
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer Genes.
Moody EW; Vagher J; Espinel W; Goldgar D; Hagerty KJ; Gammon A
JCO Precis Oncol; 2019 Dec; 3():1-8. PubMed ID: 35100725
[TBL] [Abstract][Full Text] [Related]
35. A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias.
Feurstein S; Hahn CN; Mehta N; Godley LA
Genet Med; 2022 Apr; 24(4):931-954. PubMed ID: 35063349
[TBL] [Abstract][Full Text] [Related]
36. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges.
Tawana K; Brown AL; Churpek JE
Br J Haematol; 2022 Mar; 196(6):1293-1310. PubMed ID: 34658019
[TBL] [Abstract][Full Text] [Related]
37. The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.
Kanagal-Shamanna R
Curr Hematol Malig Rep; 2021 Aug; 16(4):336-344. PubMed ID: 34028637
[TBL] [Abstract][Full Text] [Related]
38. Unique ethnic features of
Choi EJ; Cho YU; Hur EH; Jang S; Kim N; Park HS; Lee JH; Lee KH; Kim SH; Hwang SH; Seo EJ; Park CJ; Lee JH
Haematologica; 2022 Feb; 107(2):510-518. PubMed ID: 33626862
[TBL] [Abstract][Full Text] [Related]
39. Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.
Fortuno C; Lee K; Olivier M; Pesaran T; Mai PL; de Andrade KC; Attardi LD; Crowley S; Evans DG; Feng BJ; Foreman AKM; Frone MN; Huether R; James PA; McGoldrick K; Mester J; Seifert BA; Slavin TP; Witkowski L; Zhang L; Plon SE; Spurdle AB; Savage SA;
Hum Mutat; 2021 Mar; 42(3):223-236. PubMed ID: 33300245
[TBL] [Abstract][Full Text] [Related]
40. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
